Tony McHale standing in his garden, smiling.

Help every man with prostate cancer

Give the gift of research to help every man with prostate cancer live longer, healthier lives.

Donate now

Tony McHale (pictured above) discovered he had an alteration in the BRCA2 gene at the age of 61, putting him at a much higher risk of developing prostate cancer. Shortly after, Tony joined the IMPACT study at the ICR, which investigated whether regular screening would lead to earlier diagnosis of aggressive forms of the disease. Around 18 months later, the screening revealed Tony had prostate cancer. 

"Being involved in the IMPACT study saved my life. If I hadn't taken part, I'd never have known I had prostate cancer. As far as I was aware, I didn't have any symptoms – and the sooner the disease is detected and treated, the better the chances are of survival." – Tony

Godfrey's prostate cancer story

 

DJ and music promoter, Godfrey Fletcher, found out he had prostate cancer in 2015 at the age of 47, shortly after his father had also been diagnosed.

"I was so lucky that my cancer was picked up at a very early stage. I was young and fit, with no symptoms. A year after my treatment finished, I was told it had been successful. My dad wasn't so fortunate. He was diagnosed with advanced prostate cancer and passed away at 80. His experience, and mine, showed me the importance of early diagnosis."

Why we need more research into prostate cancer

We're proud of the research advances we've made over the last 20 years. Our scientists discovered the drug abiraterone; identified genetic variants that influence risk of developing the disease; and pioneered new, more precise forms of radiotherapy. But despite our research advances, some prostate cancers remain difficult to treat. This includes those diagnosed at a later stage and those more aggressive tumours, which can spread quickly and evolve to resist treatment.

That's why we urgently need better ways to detect prostate cancer earlier, predict drug resistance, and develop smarter, more personalised treatments. Your gift will help our world-leading researchers unravel the complexity of prostate cancer, to give men precise and personalised care with the right treatments at the right time, to live longer and healthier lives.

Professor Eeles's goal is to develop new tests that could be used in prostate cancer screening, helping to identify men at a higher risk. Her team showed that a simple saliva test, carried out at home, was more accurate at identifying future risk of prostate cancer for some men than the current standard blood test. 

Building on this success, they recently launched a major new study to find out whether an improved version of this test – now suitable for more diverse groups, including Black men and younger men – can help detect more cancers earlier in men at higher risk. 

Tackling drug resistance

Our research underpinned the development of olaparib, a drug that revolutionised treatment for people with BRCA-related cancers. In a recent study, Professor Johann de Bono's team showed that changes which can be spotted with a simple blood test can reveal how long a prostate cancer patient will respond to olaparib. 

The ability to predict when – and how – patients will stop responding to olaparib could help doctors personalise treatment, and in the future, guide the development of new drugs to outsmart resistance – keeping us one step ahead of prostate cancer.

Professor Johann de Bono in the laboratory, smiling.

Creating smarter, kinder treatments for every man

Our scientists are at the forefront of precision cancer medicine – developing more effective treatments with fewer side effects.

Laboratory studies co-led by Dr Adam Sharp and Professor Johann de Bono showed that NXP800 – a new drug which targets a ‘master switch’ that cancer cells hijack to support their growth – slowed prostate cancer cell growth. This innovative drug could potentially also benefit men with advanced prostate cancer that has stopped responding to standard hormone therapy.

A study co-led by Professor Emma Hall has found that men with intermediate-risk, localised prostate cancer can be treated just as effectively with five sessions of higher-dose radiation therapy as with several weeks of standard treatment. Using stereotactic body radiotherapy (SBRT), which targets tumours with pinpoint accuracy, patients can receive a highly effective treatment with far fewer hospital visits. 

A study co-led by Professor Nick James has shown that a new artificial intelligence (AI) test can select which men with high-risk prostate cancer that has not spread will require the life-extending drug abiraterone. In the STAMPEDE trial, the team found that three out of four men could be spared unnecessary treatment, making the drug – discovered by our scientists – more affordable for the NHS.

Your gift can help every man with prostate cancer live longer, healthier lives

Help someone's dad, grandad, brother, uncle, partner, or friend survive prostate cancer. Your support will help fund life-saving research – so that every man can spend more precious time with their loved ones.

Make a donation

Your gift of research can help transform the lives of every man with prostate cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Your gift of research can help transform the lives of every man with prostate cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

 Related news and blogs

12/12/25 - by

Phil Kissi, 68, was diagnosed with aggressive prostate cancer in 2006. Thanks to early diagnosis and successful surgery, he has no evidence of disease today. He explains why greater awareness around prostate cancer and scientific advances make him feel confident about the future.

In 2006, I took a day of annual leave from my busy job in the civil service to spend some time at home with my then fiancée (who is now my wife). I don’t normally watch much television, but that day, we turned on the TV and started watching an episode of the BBC’s documentary series, City Hospital.

The episode focused specifically on men’s health and in particular featured two prostate cancer patients. One had gone through testing, and his cancer had been diagnosed early. The cancer was contained within his prostate, and he underwent immediate surgery to remove it. The second man had been experiencing symptoms for a while but had left it too late. By the time he was diagnosed, his cancer had spread to his bones, and his prognosis was not very good.

At that time, I had never really heard of prostate cancer, but the stories in the programme really hit home. At the end of the episode, there was a message that came up on screen, asking anyone who had been affected by the programme or who wanted further information to call a number. 

I did that and spoke to a lovely specialist nurse. She asked me lots of questions about myself and my family history.  At that time, I was unaware that my father and both my grandfathers had had prostate cancer, but I did mention to her that they had all had problems with urination and carried bottles around with them. Based on this information and the fact that I was a Black male, she suggested I visit my GP as I was likely to be at a higher risk of getting prostate cancer. When I reflect back on it now, this was lifesaving advice.

‘We were in a race against time’

My GP was very supportive. By the time I went to see him, I had spoken to my uncle in Ghana who confirmed that my father and both grandfathers had had issues with their prostate. The GP therefore considered me to be in a vulnerable group due to my family history and agreed to me having a PSA test. The results came back slightly raised but below the margin for concern, and since I had no symptoms, he suggested we simply watch and wait, with a plan to re-test again at a later date.

A few weeks later, having done some research into prostate cancer, I was still concerned and returned to the GP.  He was surprised to see me but could see that I was worried. I asked him for another blood test and a biopsy.  He carried out an internal exam which was normal but agreed to send me for a second PSA test and biopsy.

A few weeks later, I received a letter from the hospital asking me to come in. I had a feeling something was not quite right. During my biopsy, they had taken 14 tissue samples and I had heard the nurse mention ‘black spots’. My brain had been overthinking this ever since and I had a hunch that something was wrong.

I went to my appointment with the urologist. I am usually very good at reading the room and immediately had a sense that this was not going to be good. The consultant told me that he had good news and bad news. The bad news was that I had prostate cancer and it was an aggressive type. The good news was that he thought it was all contained within my prostate.  However, due to the aggressive nature of the disease, we were in a race against time.

The urologist suggested robotic surgery to remove my prostate. This would be the best way of ensuring the cancer did not spread and would reduce the risk of any nerve damage. He offered me a few days to reflect on what I wanted to do.  I just wanted to get on with the treatment – I didn’t need to think about it.

We urgently need better ways to detect prostate cancer earlier, predict drug resistance, and develop smarter, more personalised treatments. By supporting us today, you can help our scientists make more discoveries and help ensure that every man with prostate cancer can live longer, healthier lives:

Support us

‘I cancelled my wedding and wrote my Will instead’

My diagnosis was an enormous shock. I had been planning on getting married at the time, but suddenly I was worrying that I might die. I cancelled the wedding, not wanting to put my fiancée in that position, and wrote my Will instead. I had to be realistic about things, and the focus for me at that point was fighting the disease.  I had to follow medical advice to stand the best chance of beating this.

Of course, your life flashes before you when you get a diagnosis like that. I was at the top of my career in the civil service, about to get married. I could not believe that this was happening to me at this stage of my life.  I contacted my ex-wife and made arrangements for my two sons.  Everyone around me was utterly shocked. Nobody could understand how I could have cancer when I was so fit and healthy and didn’t seem unwell at all.

Over the next few months, I had a series of different tests to make sure the cancer had not spread - bone scans, brain scans and tissue samples were taken. Then, I had my surgery.

Immediately after my operation, the surgeon came to my bedside and gave me a high-five. He was certain that they had managed to remove every bit of the cancer and that I would not need any further treatment. It was a celebration. I felt incredibly relieved, but I knew that there was still a period of uncertainty to follow.  I was regularly monitored for another couple of years but have thankfully been cancer-free ever since.

I rescheduled my wedding and got married in September 2008, with my surgeon and specialist nurse present as guests.

‘Greater awareness and scientific research means there is hope’

Following my surgery, I had some issues with incontinence, but this was a small price to pay to be alive. Last year, I had an operation to resolve it, and I no longer suffer with this problem. I feel lucky to be here. You cannot put a price on your life. 

Before my diagnosis, prostate cancer had never been talked about in my family. I have been the flag-bearer, determined to speak out about it and raise awareness within my family and beyond. My message has always been that men need to get tested; there is nothing to be ashamed about. My two sons are educated about prostate cancer and they have been regularly tested. It has been important to me to make sure they are aware. You can’t hide away and ignore the risks of this disease, otherwise you risk dying.

I feel confident about the future and believe the battle with prostate cancer will get easier and easier for all men over time. Greater awareness around the disease and new scientific research in this area means there is more hope for men going forward. It has also been great that so many public figures have opened up about their prostate cancer diagnoses – and encouraged men to get tested.

I am determined to continue raising awareness about the need for men to get tested. Early diagnosis gives you a better chance of survival.

Cancer research is extremely important. Trying to find new drugs to either make patients comfortable or find a cure are vital. I was lucky – my cancer hadn’t spread and I didn’t need any further treatment after my surgery. But I know that there would have been drugs available to me had I needed them – and these only exist thanks to research. There is a jigsaw of information to uncover when it comes to cancer, and thanks to research, we are able to understand more and piece it all together to help patients live better and longer.

Our pioneering research is transforming the lives of men with prostate cancer. But too many lives are still lost. Donate today to help fund more groundbreaking discoveries – and give hope to every dad, brother, uncle, partner or friend with prostate cancer.

Donate now